Cargando…

The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis

OBJECTIVE: We conducted a systematic review and meta-analysis aiming to assess the relationship between apolipoprotein E (APOE) gene ε2/ε3/ε4 polymorphism and breast cancer risk. METHODS: Yun-Long Liu and Hao-Min Zhang independently completed literature retrieval and data collection, and statistical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yun-Long, Zhang, Hao-Min, Pan, Hong-Ming, Bao, Yu-Hang, Xue, Jing, Wang, Tian-Chang, Dong, Xiao-Cheng, Li, Xiao-Ling, Bao, Hong-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789883/
https://www.ncbi.nlm.nih.gov/pubmed/27022282
http://dx.doi.org/10.2147/OTT.S94228
_version_ 1782420931061219328
author Liu, Yun-Long
Zhang, Hao-Min
Pan, Hong-Ming
Bao, Yu-Hang
Xue, Jing
Wang, Tian-Chang
Dong, Xiao-Cheng
Li, Xiao-Ling
Bao, Hong-Guang
author_facet Liu, Yun-Long
Zhang, Hao-Min
Pan, Hong-Ming
Bao, Yu-Hang
Xue, Jing
Wang, Tian-Chang
Dong, Xiao-Cheng
Li, Xiao-Ling
Bao, Hong-Guang
author_sort Liu, Yun-Long
collection PubMed
description OBJECTIVE: We conducted a systematic review and meta-analysis aiming to assess the relationship between apolipoprotein E (APOE) gene ε2/ε3/ε4 polymorphism and breast cancer risk. METHODS: Yun-Long Liu and Hao-Min Zhang independently completed literature retrieval and data collection, and statistical analyses were performed by Stata. Individual odds ratio (OR) and 95% confidence interval (CI) were pooled in a random-effects model using the DerSimonian–Laird method. Heterogeneity was evaluated by I(2) statistic at a significance level of 50%. Publication bias was assessed by Egger’s test. RESULTS: Eleven articles including 2,074 breast cancer patients and 2,372 controls were summarized. Using the most common allele ε3 as a reference, the ε2 (OR =0.87, 95% CI =0.72–1.05, P=0.154, I(2)=0.0%) and ε4 (OR =1.07, 95% CI =0.80–1.42, P=0.654, I(2)=71.8%) alleles were not found to be significantly associated with breast cancer risk in the overall analyses. Subgroup analyses revealed that the comparison of allele ε4 with ε3 was significant in Asians (OR =1.58, 95% CI =1.17–6.32, P=0.003, I(2)=12.1%) and in studies that used the restriction fragment length polymorphism (RFLP) genotyping method (OR =1.27; 95% CI =1.01–1.61, P=0.045, I(2)=34.3%), and was marginally significant in hospital-based studies (OR =1.33; 95% CI =0.98–1.79, P=0.065, I(2)=30.2%), without heterogeneity. Moreover, the presence of the ε2 allele was significantly associated with breast cancer in small studies (total sample size <500) (OR =0.73, 95% CI =0.54–1.00, P=0.052, I(2)=0.0%) without heterogeneity. The Egger’s test indicated low probabilities of publication bias. CONCLUSION: We observed a significant association between APOE gene ε4 allele and breast cancer risk in Asian populations. Moreover, the findings of our subgroup analyses suggest that source of controls, genotyping platform, and sample size might be the potential causes of heterogeneity.
format Online
Article
Text
id pubmed-4789883
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47898832016-03-28 The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis Liu, Yun-Long Zhang, Hao-Min Pan, Hong-Ming Bao, Yu-Hang Xue, Jing Wang, Tian-Chang Dong, Xiao-Cheng Li, Xiao-Ling Bao, Hong-Guang Onco Targets Ther Original Research OBJECTIVE: We conducted a systematic review and meta-analysis aiming to assess the relationship between apolipoprotein E (APOE) gene ε2/ε3/ε4 polymorphism and breast cancer risk. METHODS: Yun-Long Liu and Hao-Min Zhang independently completed literature retrieval and data collection, and statistical analyses were performed by Stata. Individual odds ratio (OR) and 95% confidence interval (CI) were pooled in a random-effects model using the DerSimonian–Laird method. Heterogeneity was evaluated by I(2) statistic at a significance level of 50%. Publication bias was assessed by Egger’s test. RESULTS: Eleven articles including 2,074 breast cancer patients and 2,372 controls were summarized. Using the most common allele ε3 as a reference, the ε2 (OR =0.87, 95% CI =0.72–1.05, P=0.154, I(2)=0.0%) and ε4 (OR =1.07, 95% CI =0.80–1.42, P=0.654, I(2)=71.8%) alleles were not found to be significantly associated with breast cancer risk in the overall analyses. Subgroup analyses revealed that the comparison of allele ε4 with ε3 was significant in Asians (OR =1.58, 95% CI =1.17–6.32, P=0.003, I(2)=12.1%) and in studies that used the restriction fragment length polymorphism (RFLP) genotyping method (OR =1.27; 95% CI =1.01–1.61, P=0.045, I(2)=34.3%), and was marginally significant in hospital-based studies (OR =1.33; 95% CI =0.98–1.79, P=0.065, I(2)=30.2%), without heterogeneity. Moreover, the presence of the ε2 allele was significantly associated with breast cancer in small studies (total sample size <500) (OR =0.73, 95% CI =0.54–1.00, P=0.052, I(2)=0.0%) without heterogeneity. The Egger’s test indicated low probabilities of publication bias. CONCLUSION: We observed a significant association between APOE gene ε4 allele and breast cancer risk in Asian populations. Moreover, the findings of our subgroup analyses suggest that source of controls, genotyping platform, and sample size might be the potential causes of heterogeneity. Dove Medical Press 2016-03-07 /pmc/articles/PMC4789883/ /pubmed/27022282 http://dx.doi.org/10.2147/OTT.S94228 Text en © 2016 Liu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Liu, Yun-Long
Zhang, Hao-Min
Pan, Hong-Ming
Bao, Yu-Hang
Xue, Jing
Wang, Tian-Chang
Dong, Xiao-Cheng
Li, Xiao-Ling
Bao, Hong-Guang
The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title_full The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title_fullStr The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title_full_unstemmed The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title_short The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
title_sort relationship between apolipoprotein e gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789883/
https://www.ncbi.nlm.nih.gov/pubmed/27022282
http://dx.doi.org/10.2147/OTT.S94228
work_keys_str_mv AT liuyunlong therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT zhanghaomin therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT panhongming therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT baoyuhang therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT xuejing therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT wangtianchang therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT dongxiaocheng therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT lixiaoling therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT baohongguang therelationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT liuyunlong relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT zhanghaomin relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT panhongming relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT baoyuhang relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT xuejing relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT wangtianchang relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT dongxiaocheng relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT lixiaoling relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis
AT baohongguang relationshipbetweenapolipoproteinegenee2e3e4polymorphismandbreastcancerriskasystematicreviewandmetaanalysis